FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Flurazepam Hydrochloride Capsule
Status: Currently in Shortage
»Date first posted: 08/03/2022
»Therapeutic Categories: Neurology; Other

Expand all

Chartwell Molecular Holdings LLC (Reverified 09/16/2024)

Company Contact Information:
845-268-5000 Ext. 510

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90)	Available
Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90)	Available
Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-30)	Available
Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-30)	Available

Rising Pharma Holdings, Inc. (Revised 07/02/2024)

Company Contact Information:
1-844-874-7464

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Capsule, 15 mg (NDC 0378-4415-01)	Unavailable	Anticipated availability: Q1 2025; Delay is due to manufacturing delays at the contract manufacturing facility.	Regulatory delay
Capsule, 30 mg (NDC 0378-4430-01)	Unavailable	Anticipated availability: Q1 2025; Delay is due to manufacturing delays at the contract manufacturing facility.	Regulatory delay